US OptionsDetailed Quotes
AXDX241220C2500
- 0.14
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
0.14Open0.14Pre Close0 Volume269 Open Interest2.50Strike Price0.00Turnover206.10%IV60.98%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier26DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type0.3135Delta0.3930Gamma11.71Leverage Ratio-0.0062Theta0.0003Rho3.67Eff Leverage0.0016Vega
Accelerate Diagnostics Stock Discussion
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
An automated platform designed to fight against Sepsis and Antimicrobial Resistance (AMR)
Enables rapid, automated microbial identification on the Bruker MALDI Biotyper® CA System directly from positive blood culture samples
TUCSON, Ariz., Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S....
$Borealis Foods Inc. (BRLS)$: +98.75%.
$Snap Inc. (SNAP)$: Notable increase following positive news and potential regulatory changes.
$Mullen Automotive Inc. (MULN)$: Volatile with low float, ideal for day traders.
$TransCode Therapeutics, Inc. (RNAZ)$: +55.65% due to advances in biotechnology.
$Akso Health Group (AHG)$: +67.14%, with growth in the health sector.
$Accelerate Diagnostics, Inc. (AXDX)$: +56.46%, momentum in medical diagnostics.
$Bakkt Holdings, Inc. (B...
No comment yet